Showing results (61-70 of 98) with videos related to
Sort By:
Pageof 10
Neuropeptides|June 1, 1992
Interaction of amyloid beta protein (25-35) with tachykinin receptorsP Rovero, R Patacchini, A R Renzetti, et al.Human Immunology|November 1, 1993
Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chainsD Fruci, P Rovero, G Falasca, et al.Clinical and Experimental Immunology|March 9, 2016
Label-free detection of immune complexes with myeloid cellsZ Szittner, A E H Bentlage, P Rovero, et al.Journal of Autonomic Pharmacology|August 1, 1991
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptorsL Abelli, C A Maggi, P Rovero, et al.Immunogenetics|January 1, 1994
The peptide binding specificity of HLA-B27 subtypesN Tanigaki, D Fruci, E Vigneti, et al.European Journal of Pharmacology|February 20, 1990
In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonistC A Maggi, S Giuliani, L Ballati, et al.British Journal of Pharmacology|July 1, 1990
Competitive antagonists discriminate between NK2 tachykinin receptor subtypesC A Maggi, R Patacchini, S Giuliani, et al.Biopolymers|July 1, 1995
CD and fluorescence studies of the human granulocyte-macrophage colony-stimulating factor and related peptide conformations in aqueous solutionL Casté, M Zandomeneghi, J L Houben, et al.General Pharmacology|January 1, 1989
Further studies on the motor response of the human isolated urinary bladder to tachykinins, capsaicin and electrical field stimulationC A Maggi, R Patacchini, P Santicioli, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitorsS Giuliani, R Patacchini, G Barbanti, et al.Pageof 10